Skip to main content
. 2022 Apr 18;10(4):631. doi: 10.3390/vaccines10040631

Figure 4.

Figure 4

Vesicular lesion, clinical scores, and viremia of pigs, post infection challenge. (A) Vesicular lesion observed on pigs in the immune group and control group, challenged with SVV LNSYO1-2017. (B) Clinical scores of the pigs challenged with SVV LNSYO1-2017. Data represent the mean ± SD. (C) Detection of the viremia levels in the serum of pigs challenged with SVV LNSYO1-2017. Data represent the mean ± SD. Significance was determined using ANOVA (**** p < 0.000001).